SCHEMBL34525

SCHEMBL34525

C1=NCNc2ccccc21

nearest known ligand 0.39

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
NOS2 P35228 1/20 0.39
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
PLAU P00749 1/20 0.33
ALOX15 P16050 1/20 0.30
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30051018 1.00 NOS2 (0.39) NOS2GAAMAPTPLAUALOX15
Bromide SCHEMBL7993026 0.98 NOS2 (0.38) NOS2GAAMAPTPLAU
SCHEMBL3541131 0.98 NOS2 (0.38) NOS2GAAMAPTPLAU
SCHEMBL5471703 0.78 NISCH (0.35) GAAMAPT
SCHEMBL27741572 0.77
SCHEMBL11397499 0.75 GAA (0.39) GAAMAPT
SCHEMBL11397495 0.75 GAA (0.39) GAAMAPT
SCHEMBL2516589 0.74 PLAU (0.35) GAAMAPTPLAU
SCHEMBL18321326 0.72 NISCH (0.34) GAA
SCHEMBL1384491 0.72 GAA (0.32) GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2927 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119798172-A Preparation method of Leitemivir key intermediate dihydroquinazoline ester 仁合益康集团有限公司 2025-04-11 CN claimed
CN-115819170-B Method for synthesizing chiral dihydroquinazoline compound 山西警察学院 2024-06-21 CN claimed
US-RE49897-E1 Salts of a dihydroquinazoline derivative AIC246 AG & CO. KG (DE) 2024-04-02 US claimed
EP-4244210-A1 DICHLOROPHENOL HSD17B13 INHIBITORS AND USES THEREOF Inipharm, Inc. (US) 2023-09-20 EP claimed
CN-116670118-A Dichlorophenol HSD17B13 inhibitor and application thereof 伊尼制药公司 2023-08-29 CN claimed
EP-3421454-B9 PIPERIDINE DERIVATIVE OTSUKA PHARMA CO LTD (JP) 2023-08-09 EP claimed
CN-116005178-B Synthesis method of 1,2-dihydro quinazoline compound 淮北师范大学 2023-07-18 CN claimed
CN-116005178-A Synthesis method of 1,2-dihydro quinazoline compound 淮北师范大学 2023-04-25 CN claimed
CN-115947694-A Preparation method of dihydroquinazoline compound 云南大学 2023-04-11 CN claimed
EP-3421454-B1 PIPERIDINE DERIVATIVE OTSUKA PHARMA CO LTD (JP) 2023-04-05 EP claimed
WO-2003000181-A2 DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OF DIABETES MERCK & CO., INC. (US) 2003-01-03 WO claimed
JP-2002537391-A 2002-11-05 JP claimed
WO-2002083884-A2 IMMOBILIZING METHOD AND ARRANGEMENTS OF COMPOUNDS, WHICH ARE PRODUCED THEREWITH, ON A PLANAR SURFACE JERINI AG (DE) 2002-10-24 WO claimed
EP-1155012-A1 ANTI-CANCER DIHYDROQUINAZOLINE DERIVATIVES Cancer Research Ventures Limited (GB) 2001-11-21 EP claimed
WO-2000050417-A1 ANTI-CANCER DIHYDROQUINAZOLINE DERIVATIVES CANCER RESEARCH VENTURES LIMITED (GB) 2000-08-31 WO claimed
CN-1036394-C Process for preparing quinolone derivatives OTSUKA PHARMA CO LTD (JP) 1997-11-12 CN claimed
US-4880892-A PHOSPHONIUM OR PHOSPHORANE CATALYST, PROTECTIVE COATINGS CIBA-GEIGY CORPORATION (US) 1989-11-14 US claimed
US-4562449-A COLOR FORMERS FOR PRESSURE SENSITIVE OR HEAT SENSITIVE RECORDING MATERIAL CIBA-GEIGY CORPORATION (US) 1985-12-31 US claimed
US-4503227-A HEAT SENSITIVE OR PRESSURE SENSITIVE RECORDING CIBA-GEIGY CORPORATION (US) 1985-03-05 US claimed
US-4094811-A REDUCING SILVER SALTS IN THE PRESENCE OF A HETEROCYCLIC 5- OR 6-MEMBERED NITROGEN COMPOUND AGFA-GEVAERT AKTIENGESELLSCHAFT (DT) 1978-06-13 US claimed